Bleomycin
Bleomycin has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals.
Research on it is growing 20% slower than aging research as a whole: 57 papers in the latest year counted
At a glance
The findings reach mice, none yet in people; independent labs found the same change in cells and mice. 17 independent labs in 10 countries; 111 trials, 49 with no results posted.
- 17 independent labs in 10 countries
- 111 trials, 49 with no results posted
- Funders: National Institutes of Health and others
- 11 of 34 findings with company ties
What did studies of bleomycin find?
25Studies of bleomycin measured 25 outcomes; the most studied is cellular senescence (7 studies).
Cellular senescence
upin human cells4upin mice3
7 studies
Cellular senescence
upin human cells4upin mice3
Bleomycin induces cellular senescence in mice (single and repetitive regimen).
“Pulmonary cellular senescence was evident from a markedly increased %-area of p21+ staining and a higher proportion of p16+ myofibroblasts (α-SMA+) in both models.”
Animalssingle and repetitive regimenintratracheal instillationlung
American Journal of Respiratory and Critical Care Medicine
Bleomycin induces cellular senescence in human 3D lung tissue culture.
“We validated SenSet in a highly complex ex vivo human 3D lung tissue culture model subjected to the senescence inducers bleomycin, doxorubicin, or irradiation”
Cellsin human 3D lung tissue culturelung
SenSet defines cell-type specific senescence signatures in the aged human lung
The EMBO journal
Bleomycin increases cellular senescence in mice (single oropharyngeal dose in 17-month-old mice, assessed 10 weeks after administration).
“Lung histology and immunohistochemistry (IHC) confirm persistence of fibrosis and senescence in mice 10 weeks after bleomycin administration.”
Animalssingle oropharyngeal dose in 17-month-old mice, assessed 10 weeks after administrationlungsingle dose10 weeks
bioRxiv (Cold Spring Harbor Laboratory)Preprint
Bleomycin induces cellular senescence in human cells (cultured chondrocytes, compared with ENU-treated cells).
“In vitro, senescence was observed in bleomycin-treated chondrocytes, but not in ENU-treated cells.”
Cellscultured chondrocytes, compared with ENU-treated cells
Cellular Senescence in Human Chondrocytes in Relation to Osteoarthritis
Cartilage
Bleomycin induces cellular senescence in primary human lung fibroblasts from control, IPF or COPD patients.
“H2O2 and bleomycin but not TGF-β1 induced senescence in phLF from different disease origins.”
Cellsin primary human lung fibroblasts from control, IPF or COPD patients
Stimuli-Specific Senescence of Primary Human Lung Fibroblasts Modulates Alveolar Stem Cell Function
Cells
Bleomycin induces cellular senescence in mice (ex vivo aorta culture and Matrigel subcutaneous implantation).
“The results revealed that vessels in the bleomycin group exhibited significant senescence than those in the control group”
Animalsex vivo aorta culture and Matrigel subcutaneous implantationaorta
An Ex Vivo Aorta Culture Model to Study Vascular Cellular Senescence
Advanced biology
Bleomycin induces cellular senescence in primary human lung fibroblasts.
“H 2 O 2 and bleomycin treatment induced a senescent phenotype in phLF”
Cellsin primary human lung fibroblasts
bioRxiv (Cold Spring Harbor Laboratory)Preprint
DNA damage response
upin mice1
1 study
DNA damage response
upin mice1
Bleomycin induces DNA damage response in mice (single and repetitive regimen).
“RNA sequencing revealed significant upregulation of key genes associated with the senescence-associated secretory phenotype (SASP) and DNA damage responses in both models”
Animalssingle and repetitive regimenintratracheal instillationlung
American Journal of Respiratory and Critical Care Medicine
Senescence-associated secretory phenotype (SASP)
upin mice1
1 study
Senescence-associated secretory phenotype (SASP)
upin mice1
Bleomycin activates senescence-associated secretory phenotype (SASP) in mice (single and repetitive regimen).
“RNA sequencing revealed significant upregulation of key genes associated with the senescence-associated secretory phenotype (SASP) and DNA damage responses in both models”
Animalssingle and repetitive regimenintratracheal instillationlung
American Journal of Respiratory and Critical Care Medicine
Pulmonary fibrosis
upin mice1
1 study
Pulmonary fibrosis
upin mice1
Bleomycin induces pulmonary fibrosis in mice (single and repetitive regimen).
“The single and repetitive BLEO-IPF mouse models demonstrated impaired pulmonary function and lung fibrosis accompanied by an evolving cellular senescence phenotype”
Animalssingle and repetitive regimenintratracheal instillationlung
American Journal of Respiratory and Critical Care Medicine
Pulmonary function
downin mice1
1 study
Pulmonary function
downin mice1
Bleomycin impairs pulmonary function in mice (single and repetitive regimen).
“The single and repetitive BLEO-IPF mouse models demonstrated impaired pulmonary function and lung fibrosis accompanied by an evolving cellular senescence phenotype”
Animalssingle and repetitive regimenintratracheal instillationlung
American Journal of Respiratory and Critical Care Medicine
MYSM1
downin human cells1
1 study
MYSM1
downin human cells1
Bleomycin decreases MYSM1 in bleomycin-induced THP-1 senescence model.
“Similarly, in the bleomycin-induced in vitro model, MYSM1 expression was suppressed during DNA damage-driven inflammatory aging”
Cellsin bleomycin-induced THP-1 senescence model
Clinical rheumatology
Proinsulin
no changein human cells1
1 study
Proinsulin
no changein human cells1
Bleomycin showed no clear effect on proinsulin in human cells (bleomycin-induced senescence).
“no significant differences in proinsulin or insulin content were observed, compared with control islets”
Cellsbleomycin-induced senescencepancreatic islet
Insulin production is sustained during DNA damage-mediated senescence in adult human beta cells
Diabetologia
Insulin
no changein human cells1
1 study
Insulin
no changein human cells1
Bleomycin showed no clear effect on insulin in human cells (bleomycin-induced senescence).
“no significant differences in proinsulin or insulin content were observed, compared with control islets”
Cellsbleomycin-induced senescencepancreatic islet
Insulin production is sustained during DNA damage-mediated senescence in adult human beta cells
Diabetologia
Lung function
downin mice1
1 study
Lung function
downin mice1
Bleomycin impairs lung function in mice (repetitive bi-weekly instillations, study week 8) (significantly reduced).
“with FEV0.1 being significantly reduced on study week 8.”
Animalsrepetitive bi-weekly instillations, study week 8repetitive bi-weekly intratracheal instillationslungstudy week 8malesn = 30
Physiological reports
Senescent myofibroblasts
upin mice1
1 study
Senescent myofibroblasts
upin mice1
Bleomycin increases senescent myofibroblasts in mice (repetitive bi-weekly instillations, assessed 8 weeks after baseline).
“Histological analysis revealed ongoing pulmonary inflammation and accumulation of senescent myofibroblasts.”
Animalsrepetitive bi-weekly instillations, assessed 8 weeks after baselinerepetitive bi-weekly intratracheal instillationslung8 weeks after baselinemalesn = 30
Physiological reports
All 25Fewer
What is bleomycin linked with?
2Studies link bleomycin with 2 measures: chronic fibrosis gene expression signature and pulmonary fibrosis.
Chronic fibrosis gene expression signature
upin mice1
1 study
Chronic fibrosis gene expression signature
upin mice1
Bleomycin is associated with chronic fibrosis gene expression signature in mice (single oropharyngeal dose in 17-month-old mice).
“bulk RNA sequencing (RNA-Seq) analysis revealed a distinct set of gene expression signatures that is more consistent with chronic human fibrosis.”
Animalssingle oropharyngeal dose in 17-month-old micelungsingle dose
bioRxiv (Cold Spring Harbor Laboratory)Preprint
Pulmonary fibrosis
upin mice1
1 study
Pulmonary fibrosis
upin mice1
Bleomycin is associated with pulmonary fibrosis in young mice (R2 = 0.92).
“BLM-induced TLSs were larger and less compact than those in aged lungs, correlating with fibrotic severity (R2 = 0,92).”
Animalsin young micelung
Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft
Trial sponsors
Company4 trialsPhase 4397 people
Company2 trialsPhase 3445 people
Company1 trialPhase 3
Company2 trialsPhase 2486 people
Company2 trialsPhase 122 people
Company1 trialPhase 151 people
Second Affiliated Hospital, Zhejiang University, School of Medicine
1 trialPhase 4200 people
1 trialPhase 4135 people